Early Predictors of Acute Kidney Injury in COVID-19 Patients

Link to article at PubMed

Nephrology (Carlton). 2021 Jan 27. doi: 10.1111/nep.13856. Online ahead of print.


AIM: Coronavirus disease 2019 (COVID-19) related to acute kidney injury (AKI) is associated with poor prognosis and an increased risk of mortality. Early predicting COVID-19 related renal dysfunction may affect the prognosis of COVID-19 as well as reducing the risk of AKI. This study aims to determine the frequency of COVID-19 related AKI and to identify the early predictors of AKI.

METHODS: This study is a single-center, retrospective, observational study. Hospitalized confirmed COVID-19 patients between 24 March 2020 and 31 May 2020 were included in the study. All patients were evaluated for renal dysfunctions with urine dipstick, protein/creatinine ratio, albumin/creatinine ratio in spot urine, serum cystatin C, serum creatinine level on hospital admission, and 28th day of hospital admission. To assess the utility of these parameters to predict AKI, a receiver-operating characteristic curve was generated and the area under the curve (AUC) was calculated.

RESULTS: 348 patients were included. The average incidence of AKI was 4.9% (n=17). The incidence of AKI in mild, moderate and severe COVID-19 cases was 1.3% (n=4), 9.0 % (n=3) and 76.9% (n=10), respectively. Proteinuria was detected in 7.8% (n=27) of patients with a urine dipstick test. In spot urine analysis, proteinuria was found in 20.1% (n=70) of patients. The frequency of persistent proteinuria was 5.2% (n=18). The AUC value of serum cystatin C, D-dimer and albumin/creatinine ratio to predict COVID-19 related AKI were 0.96 (0.90 to 1.0), 0.94 (0.89 to 0.98) and 0.95 (0.91 to 0.98).

CONCLUSION: In COVID-19 patients with normal serum creatinine levels on hospital admission, albuminuria, serum cystatin C and D-dimer levels may be an early predictor of COVID-19 related AKI and these patients should be monitored closely for AKI. Since the sample size in the AKI group was small, our study results should be confirmed with larger cohort studies.

PMID:33502771 | DOI:10.1111/nep.13856

Leave a Reply

Your email address will not be published. Required fields are marked *